Novartis AG Acquires Costim Pharmaceuticals for Undisclosed Sum

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9a659bac-b337-435e-94bd-3befd2e8fc49
Date
2/17/2014
Company Name
Costim Pharmaceuticals
Mailing Address
200 Clarendon Street 54th Floor Boston, MA 02116
Company Description
The company is developing a focused and highly attractive pipeline of antibody agents directed to costimulatory targets for the treatment of cancer.
Website
http://www.costim.com
Transaction Type
M&A
Transaction Amount
Undisclosed
Transaction Round
Proceeds Purposes
M&A Terms
Financial terms of the deal were not disclosed.